Rubella

Rate of national measles cases highlights importance of vaccination

Retrieved on: 
Thursday, March 21, 2024

Nationally, the total number of measles cases has already reached the level that occurred during the entire year of 2023.

Key Points: 
  • Nationally, the total number of measles cases has already reached the level that occurred during the entire year of 2023.
  • Infants as young as 6 months can receive the first dose if traveling to areas where the measles infection rate is high.
  • Herd immunity, achieved through a measles vaccination rate of 95% or more, is crucial for preventing disease outbreaks in the community and protecting vulnerable populations who cannot receive vaccines.
  • The measles vaccine, given as part of the MMR (measles, mumps and rubella) vaccine, is extremely effective, giving those vaccinated with just one dose 93% protection against measles infection.

World Market for Vaccines 2024: From Smallpox to Polio - The Impact on Global Health - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024

The World Market for Vaccines, 2024 offers the most up-to-date and comprehensive analysis of adult and pediatric preventative vaccines.

Key Points: 
  • The World Market for Vaccines, 2024 offers the most up-to-date and comprehensive analysis of adult and pediatric preventative vaccines.
  • Since the early 2000s, the publisher has consistently published new editions of The World Market for Vaccines every two years.
  • The report includes market forecasts, company market share data, and expert market estimates for different vaccine categories.
  • The World Market for Vaccines, 2024 also examines market trends for human vaccines used to prevent various diseases.

How memes transformed from pics of cute cats to health disinformation super-spreaders

Retrieved on: 
Monday, February 12, 2024

Our research shows that memes form part of a highly sophisticated strategy to spread and monetise health disinformation.

Key Points: 
  • Our research shows that memes form part of a highly sophisticated strategy to spread and monetise health disinformation.
  • Dismissing them as harmless jokes is to grossly underestimate their influence – and bolsters their power to spread potentially harmful health messages.

Anti-vaccine memes have a long history


Memes aren’t a recent invention. They have featured prominently in anti-vaccination messaging for centuries.
When widespread smallpox immunisation began in the early 19th century, political cartoons published in print media used memes (see image below) to evoke fear about the safety of the vaccine.

  • The meme “vaccines cause autism”, which appeared on billboards and was circulated widely in the media, provoked doubts about the safety of the vaccine.
  • The internet enables memes to be created anonymously, repurposed and shared at scale – making them a highly effective medium for spreading health disinformation.
  • Memes play an integral role in disinformation campaigns by facilitating fear, uncertainty and doubt.

Influencers and money

  • Our study analysed how popular anti-vaccine influencers used memes to galvanise the anti-vaccine movement during the COVID pandemic.
  • First, memes were used to vilify the government and social institutions, portraying them as corrupt and politically compromised.
  • Influencers suggested the unvaccinated were being persecuted, using evocative imagery to imply a false equivalence between those who remain unvaccinated by choice and the persecution of Jews during the Holocaust.
  • Vaccination was associated with infertility, low sex drive and a lack of critical thinking.
  • To establish group membership and promote a sense of belonging, influencers referred to those who are anti vaccines as their “soul family”.

Going viral – and avoiding challenge

  • Several influencers provided their followers with “meme drops”: packages of memes with dissemination instructions.
  • These memes were tested and produced in meme factories, then distributed monthly to a mass audience via personal newsletters and websites, encouraging followers to spread anti-vaccination content.
  • By adapting memes to current affairs, influencers increased their relevance and likelihood of going viral.
  • Under the protective guise of humour and satire, memes can evade fact checkers and content moderators while promoting anti-vaccine myths and unauthorised treatments.
  • Memes may not look threatening – but that’s why they are such effective super spreaders of health disinformation.


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa

Retrieved on: 
Sunday, November 26, 2023

The study, completed by the University of the Sunshine Coast, in Queensland, Australia, involved the delivery of a measles and rubella (MR) vaccine using the Vaxxas high-density microarray patch (HD-MAP) technology.

Key Points: 
  • The study, completed by the University of the Sunshine Coast, in Queensland, Australia, involved the delivery of a measles and rubella (MR) vaccine using the Vaxxas high-density microarray patch (HD-MAP) technology.
  • Study participants receiving the MR vaccine delivered by HD-MAP, showed a significant increase in neutralizing antibodies compared to placebo and a comparable response to the same comparator vaccine delivered with needle and syringe.
  • “We are incredibly pleased with the results of this groundbreaking clinical trial,” David Hoey, Vaxxas Chief Executive Officer, said.
  • This planned Phase I/II MR clinical program will be supported in part by an additional grant from the Bill & Melinda Gates Foundation.

Bioxytran Gets Broad Patent Coverage on 60+ Viruses

Retrieved on: 
Tuesday, October 24, 2023

BOSTON, MASSACHUSETTS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (BIXT), (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral diseases, announced that the U.S Patent and Trademark Office (USPTO) has published the Company’s patent application WO2023178228A1 Lectin-binding carbohydrates for treating viral infections. The pending patent covers broad claims about the use of hundreds of combinations of antiviral complex carbohydrate drugs to treat over 60 named viruses.

Key Points: 
  • The pending patent covers broad claims about the use of hundreds of combinations of antiviral complex carbohydrate drugs to treat over 60 named viruses.
  • This patent represents what we believe is a new direction in the evolution of antiviral therapies that originally started during the HIV epidemic.
  • This pending patent with its broad claims also shows the Company is well-positioned with respect to its intellectual property portfolio.
  • This patent covers some of the largest indications in virology and includes viruses like COVID-19, influenza, herpes, Epstein-Barr, shingles, hepatitis C, measles, mumps, and rubella.

World Emerging Infectious Disease Diagnostics Market Research Report 2023: Respiratory Infections Take Center Stage in Infectious Disease Diagnostics Post-COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 25, 2023

The emergence of the COVID-19 pandemic has had a profound and far-reaching impact on infectious disease diagnostics worldwide.

Key Points: 
  • The emergence of the COVID-19 pandemic has had a profound and far-reaching impact on infectious disease diagnostics worldwide.
  • North America, encompassing both the United States and Canada, currently holds the largest share in the global emerging infectious disease diagnostics market.
  • Some of the common bacterial infections include respiratory infections such as tuberculosis and streptococcal infections and sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis.
  • Hospitals and clinics play a critical role in the field of infectious disease diagnostics, serving as important centers for patient evaluation and testing.

Vaccine Journal Highlights the Potential for Self-Administration of Vaccines Using Vaxxas High-Density Microarray Patch (HD-MAP)

Retrieved on: 
Thursday, October 19, 2023

The publication outlines the potential for Vaxxas’ HD-MAP to enhance vaccine performance as well as increasing rates and acceptance of vaccination based on needle-free self-administration.

Key Points: 
  • The publication outlines the potential for Vaxxas’ HD-MAP to enhance vaccine performance as well as increasing rates and acceptance of vaccination based on needle-free self-administration.
  • The HD-MAP, upon which vaccines are ‘printed’ and dried, also provides storage and distribution benefits due to reduced cold chain requirements generally associated with vaccines delivered by needle and syringe.
  • Vaxxas is advancing a robust pipeline of pre-clinical and clinical stage HD-MAP vaccine candidates and has recently concluded multiple Phase I clinical studies.
  • The current Vaxxas pipeline targets COVID-19, seasonal and pandemic influenza, typhoid, measles and rubella, and cancer.

Global Vaccine Market Anticipated to Reach $92.32 Billion by 2028: Players Include GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer and CSL - ResearchAndMarkets.com

Retrieved on: 
Friday, September 8, 2023

Influenza vaccines reduce the risk of illness by 40% to 60% worldwide, including in the United States.

Key Points: 
  • Influenza vaccines reduce the risk of illness by 40% to 60% worldwide, including in the United States.
  • Emerging markets are witnessing a surge in demand for influenza vaccines due to high disease prevalence and limited access to vaccination.
  • Combo Vaccines: Combination vaccines that provide protection against multiple diseases with a single shot are gaining popularity.
  • Government initiatives, growing awareness of the benefits of vaccination, and advancements in vaccine technology have fueled their growth.

Measles: it's not just London that's at risk of an outbreak – it's all of the UK

Retrieved on: 
Thursday, July 27, 2023

The UK lost its measles-free status in 2019, indicating that the measles virus was circulating and there was inadequate vaccination to prevent its spread.

Key Points: 
  • The UK lost its measles-free status in 2019, indicating that the measles virus was circulating and there was inadequate vaccination to prevent its spread.
  • The virus spreads like wildfire among the unvaccinated, as demonstrated recently when seven unvaccinated children at a nursery school in Stoke-on-Trent nursery caught the bug.
  • There are no specific drugs for measles, so treatment is to help relieve symptoms and address complications, such as bacterial infections.
  • This pattern is seen globally, with many countries yet to attain the levels of routine immunisation coverage they had pre-pandemic.
  • For MMR, a national catch-up campaign is under way, and many regions have set up measles-elimination groups.
  • If this work is successful, hopefully the UK will be able to regain its measles-free status.

Measles: how declining vaccination levels in London are threatening herd immunity

Retrieved on: 
Tuesday, July 18, 2023

For 60 years, measles has been preventable by a widely available vaccine, so why is London facing a potential disaster now?

Key Points: 
  • For 60 years, measles has been preventable by a widely available vaccine, so why is London facing a potential disaster now?
  • This means one infected child can pass on the disease to 12 to 18 other children in a completely susceptible population.
  • The current levels of MMR coverage in England, particularly in London, are well below the 95% threshold.
  • The COVID pandemic has seen vaccination levels drop further, creating a perfect storm of low immunity levels.
  • Estimated immunity levels for different age groups, London and England While only three-quarters of eligible five-year-olds in London have received their second MMR dose, immunity levels are not the same across all age groups.
  • The UKHSA has sought to work out immunity levels in different age groups to better understand the risk of outbreaks.
  • With its consistently low vaccination levels, London is more likely to face an outbreak than the rest of the UK.